The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era

Detalles Bibliográficos
Autores principales: Kobayashi, T, Kuroda, J, Yokota, I, Tanba, K, Fujino, T, Kuwahara, S, Isa, R, Yamaguchi, J, Kawata, E, Akaogi, T, Uchiyama, H, Kaneko, H, Uoshima, N, Kobayashi, Y, Teramukai, S, Taniwaki, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742628/
https://www.ncbi.nlm.nih.gov/pubmed/26771809
http://dx.doi.org/10.1038/bcj.2015.111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742628/
https://www.ncbi.nlm.nih.gov/pubmed/26771809
http://dx.doi.org/10.1038/bcj.2015.111

Ejemplares similares